Abbreviations: NSCLC: Non-small Cell Lung Cancer; Adenoca: Adenocarcinoma; NOS: Not Otherwise Specified; EGFR: Epidermal Growth Factor Receptor; ALK: Echinoderm Microtubule-Associated Protein-like 4-anaplastic Lymphoma Kinase; TKI: Tyrosine Kinase Inhibitor; Pt: Platinum

Figure 1: A: Majority of treatment guidelines for advanced NSCLC. B: Present guideline for advanced NSCLC in Japan and Italy. C: Future guideline for advanced NSCLC based on driver gene mutations.